Skip to main content

Want a detailed portfolio tracker?

Invivyd (IVVD) P/E (2021 - 2026)

Invivyd (IVVD) P/E from Sep 30, 2021 to Jul 21, 2026. The TTM Invivyd (IVVD) P/E is -1.91. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Invivyd (IVVD)

YearP/EChange
2026-1.91-73.22%
2025-7.14+2191.89%
2024-0.31-87.75%
2023-2.54+112.34%
2022-1.20-100.09%
20211.35KN/A

Comparison Invivyd (IVVD) P/E with competitors

Invivyd (IVVD) P/E is -1.91.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.22%
ENLVEnlivex Ltd0.07-103.91%
FGENFibroGen Inc0.24-112.55%
CHRSCoherus Biosciences Inc0.85-144.37%
FBIOFortress Biotech Inc0.95-149.63%
ORMPOramed Pharmaceuticals Inc1.50-178.60%
AGENAgenus Inc3.01-257.38%
INVAInnoviva Inc3.15-264.94%
VXRTVaxart Inc3.55-285.63%
CRMDCorMedix Inc3.63-289.75%
CVACCureVac N.V.4.45-332.48%
GLPGGalapagos NV4.86-354.09%
SRPTSarepta Therapeutics Inc4.88-355.30%
ABEOAbeona Therapeutics Inc5.39-381.73%
ABUSArbutus Biopharma Corp5.60-392.62%
ZVRAZevra Therapeutics Inc5.89-407.87%
SPROSpero Therapeutics Inc6.23-425.71%
CGENCompugen Ltd6.31-430.18%
RIGLRigel Pharmaceuticals6.87-459.37%
SLXNSilexion Therapeutics Corp7.30-481.54%
OMEROmeros Corporation9.26-584.18%
AUPHAurinia Pharmaceuticals Inc9.58-601.24%
PLXProtalix BioTherapeutics Inc10.89-669.53%
ACADAcadia Pharmaceuticals Inc11.73-713.33%
TBPHTheravance Biopharma Inc12.26-741.24%
ADMAAdma Biologics Inc12.42-749.40%
HRMYHarmony Biosciences Holdings Inc13.82-822.71%
SABSSAB Biotherapeutics Inc14.14-839.24%
NAGENiagen Bioscience Inc14.82-874.90%
INCYIncyte Corp15.82-927.43%
REGNRegeneron Pharmaceuticals Inc15.86-929.21%
PBYIPuma Biotechnology Inc17.32-1005.51%
CPRXCatalyst Pharmaceuticals Inc17.44-1011.97%
EXELExelixis Inc17.54-1017.14%
TGTXTG Therapeutics Inc18.97-1091.81%
MDXGMimedx Group Inc20.55-1174.78%
XOMAXOMA Royalty Corp22.87-1296.24%
ARGXArgen X SE24.30-1370.68%
CTMXCytomX Therapeutics Inc24.82-1398.03%
XOMAOXOMA Royalty Corp25.34-1425.42%
HALOHalozyme Therapeutics Inc25.62-1440.01%
XOMAPXOMA Royalty Corp25.67-1442.43%
VRTXVertex Pharmaceuticals Inc27.99-1564.00%
RPRXRoyalty Pharma plc - Class A28.69-1600.23%
SLNOSoleno Therapeutics Inc29.02-1617.37%
ASNDAscendis Pharma A/S30.09-1673.34%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2082.63%
APLSApellis Pharmaceuticals Inc39.02-2140.64%
BMRNBiomarin Pharmaceutical Inc42.21-2307.49%
KRYSKrystal Biotech Inc45.34-2471.26%
ONCBeiGene Ltd69.54-3736.66%
PHARPharming Group N.V.75.03-4023.50%
TECHBio-Techne Corp101.96-5431.97%
VCELVericel Corp109.92-5848.40%
ALNYAlnylam Pharmaceuticals Inc117.96-6269.05%
GMABGenmab140.29-7436.59%
TLXTelix Pharmaceuticals Ltd162.15-8579.87%
CORTCorcept Therapeutics Inc212.86-11231.50%